Valiant Laboratories Limited (NSE:VALIANTLAB)
India · Delayed Price · Currency is INR 67.50
-0.59 (-0.87%)
Apr 22, 2026, 3:29 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 3.67 billion as of April 22, 2026. Its market cap has increased by 8.87% in one year.
Market Cap
3.67B
Enterprise Value
3.57B
Revenue
2.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
67.50
Market Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 3.67B, a decrease of -50.44%. That is a compound annual growth rate of -24.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 3.70B | -2.73% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 13.56B |
| Beta Drugs | 13.29B |
| Jagsonpal Pharmaceuticals | 12.45B |
| Ind-Swift Laboratories | 12.04B |
| Sigachi Industries | 8.56B |
| Bafna Pharmaceuticals | 3.16B |
| Nectar Lifesciences | 2.39B |
| Brooks Laboratories | 1.93B |